[Federal Register Volume 73, Number 179 (Monday, September 15, 2008)]
[Notices]
[Pages 53280-53281]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E8-21461]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application; 
Correction

    On August 6, 2008, the Drug Enforcement Administration (DEA) 
published a Notice of Application for Registration for Chattem 
Chemicals Inc., 3801 St. Elmo Avenue, Building 18, Chattanooga, 
Tennessee 37409 in the Federal Register pursuant to 21 CFR 1301.33(a) 
(73 FR 45784). On May 28,

[[Page 53281]]

2008, Chattem Chemicals Inc., had made application by renewal to DEA as 
a bulk manufacturer of the certain basic classes of controlled 
substances listed in schedules I and II. The Notice of Application 
published August 6, 2008, listed the following basic classes of 
controlled substances for which Chattem Chemicals Inc. sought 
registration as a bulk manufacturer:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
 4-Methoxyamphetamine (7411)...............   I
 Difenoxin (9168)..........................   I
 Amphetamine (1100)........................   II
 Methamphetamine (1105)....................   II
 Methylphenidate (1724)....................   II
 Pentobarbital (2270)......................   II
 Codeine (9050)............................   II
 Oxycodone (9143)..........................   II
 Hydrocodone (9193)........................   II
 Meperidine (9230).........................   II
 Dextropropoxyphene, bulk (non-dosage         II
 forms) (9273).
 Morphine (9300)...........................   II
 Thebaine (9333)...........................   II
 Noroxymorphone (9668).....................   II
 Alfentanil (9737).........................   II
 Sufentanil (9740).........................   II
 Fentanyl (9801)...........................   II
------------------------------------------------------------------------

    DEA inadvertently did not include the following substances for 
which Chattem Chemicals Inc. also seeks registration as a bulk 
manufacturer:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
 Lisdexamfetamine Mesylate (1205)..........   II
 Dihydrocodeine (9120).....................   II
 Dihydromorphine (9145)....................   II
 Hydromorphone (9150)......................   II
 Oripavine (9330)..........................   II
 Oxymorphone (9652)........................   II
 Reminfentanil (9739)......................   II
------------------------------------------------------------------------

    The company plans to manufacture the listed controlled substances 
in bulk for distribution to its customers.
    Any other such applicant, and any person who is presently 
registered with DEA to manufacture such substances, may file comments 
or objections to the issuance of the proposed registration pursuant to 
21 CFR 1301.33(a).
    Any such written comments or objections should be addressed, in 
quintuplicate, to the Drug Enforcement Administration, Federal Register 
Representative (ODL), 8701 Morrissette Drive, Springfield, Virginia 
22152.
    As DEA inadvertently did not include all basic classes of 
controlled substances for which Chattem Chemicals Inc. sought 
registration in the Notice of Application published August 6, 2008, DEA 
is extending the comment period for this application in accordance with 
21 CFR 1301.33(a). Therefore, the comment period for this application 
is extended from October 6, 2008 to November 14, 2008.

    Dated: September 8, 2008.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. E8-21461 Filed 9-12-08; 8:45 am]
BILLING CODE 4410-09-P